Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Vaccine|October 5, 2010
Dendritic cells transfected with Her2 antigen-encoding RNA replicons cross-prime CD8 T cells and protect mice against tumor challengeBirgit Edlich, Leah J Hogdal, Barbara Rehermann, et al.Oncotargets and Therapy|March 7, 2017
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trialSylvia Guetz, Amanda Tufman, Joachim von Pawel, et al.Anticancer Research|October 25, 2017
Vinflunine in the Treatment of Upper Tract Urothelial Carcinoma - Subgroup Analysis of an Observational StudyHendrik Heers, Patrick DE Geeter, Peter J Goebell, et al.Hepatology (Baltimore, Md.)|September 8, 2011
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patientsBirgit Edlich, Golo Ahlenstiel, Aintzane Zabaleta Azpiroz, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2016
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancerMichael Flentje, Rudolf M Huber, Walburga Engel-Riedel, et al.Gastroenterology|July 12, 2011
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis CGolo Ahlenstiel, Birgit Edlich, Leah J Hogdal, et al.Gastroenterology|September 15, 2009
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent mannerGolo Ahlenstiel, Rachel H Titerence, Christopher Koh, et al.Gut|February 12, 2013
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis CYaron Rotman, Mazen Noureddin, Jordan J Feld, et al.Pageof 1